Canada - engelsk - Health Canada

pfizer canada ulc - leucovorin (leucovorin calcium) - solution - 10mg - leucovorin (leucovorin calcium) 10mg - antidotes

Singapore - engelsk - HSA (Health Sciences Authority)

pfizer private limited - calcium folinate eqv folinic acid - injection - 10 mg/ml - calcium folinate eqv folinic acid 10 mg/ml

Israel - engelsk - Ministry of Health

teva israel ltd - calcium folinate - tablets - calcium folinate 16.2 mg - detoxifying agents for antineoplastic treatment - counteracts the action of folic acid antagonists. improves blood picture in megaloblastic anemias due to folate deficiency.

USA - engelsk - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - leucovorin calcium (unii: rpr1r4c0p4) (leucovorin - unii:q573i9dvlp) - leucovorin calcium for injection rescue is indicated after high dose methotrexate therapy in osteosarcoma. leucovorin calcium for injection is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists. leucovorin calcium for injection is indicated in the treatment of megaloblastic anemias due to folic acid deficiency when oral therapy is not feasible. leucovorin calcium for injection is also indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer. leucovorin calcium for injection should not be mixed in the same infusion as 5-fluorouracil because a precipitate may form. leucovorin calcium is improper therapy for pernicious anemia and other megaloblastic anemias secondary to the lack of vitamin b12 . a hematologic remission may occur while neurologic manifestations continue to progress.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate -

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 8.1 mg/ml equivalent to 7.5 mg folinic acid;  ;   - solution for injection - 15 mg/2ml - active: calcium folinate 8.1 mg/ml equivalent to 7.5 mg folinic acid     excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml;  ;   - solution for injection - 300 mg/30ml - active: calcium folinate 10.5 mg/ml     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml (4% overage);  ;   - solution for injection - 50 mg/5ml - active: calcium folinate 10.5 mg/ml (4% overage)     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 18.6mg equivalent to folinic acid 15 mg - tablet - 15 mg - active: calcium folinate 18.6mg equivalent to folinic acid 15 mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - calcium folinate - oral tablet - 15mg